| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. REPL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 533.6K | $5.97M | - | |
| Other | 201.6K | $2.25M | - | |
| Other | 199.7K | $2.23M | - | |
| CFO | 194.4K | $2.17M | - | |
| Other | 78.3K | $875.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | Omega Fund Iv, L.P.81 | 10% Owner | Sell | 5,249 | $45.00 | $236,205.00 | -0.1% | |
| Jan 26, 2021 | Rhodes Jason P78 | Director | Sell | 5,558 | $46.14 | $256,446.12 | -0.6% | |
| Jan 26, 2021 | Omega Fund Iv, L.P.81 | Director, 10% Owner | Sell | 30,350 | $45.42 | $1,378,444.10 | -0.3% | |
| Jan 22, 2021 | Omega Fund Iv, L.P.81 | Director, 10% Owner | Sell | 11,359 | $45.04 | $511,657.57 | -0.1% | |
| Jan 22, 2021 | Coffin Robert61 | President &Chief R&D Officer | Sell | 60,000 | $44.43 | $2,665,973.36 | -1.7% | |
| Jan 19, 2021 | Esposito Pamela71 | Chief Business Officer | Sale+OE | 55,000 | $43.99 | $2,419,343.60 | -7.2% | |
| Jan 19, 2021 | Astley-Sparke Philip47 | Chief Executive Officer | Sell | 50,000 | $43.76 | $2,187,789.71 | -0.5% | |
| Jan 19, 2021 | Love Colin72 | Chief Operating Officer | Sell | 30,000 | $43.24 | $1,297,064.98 | -0.6% | |
| Jan 15, 2021 | Omega Fund Iv, L.P.81 | Director, 10% Owner | Sell | 19,580 | $45.10 | $883,053.80 | -0.2% | |
| Jan 14, 2021 | Franchi Jean M. | Chief Financial Officer | Sale+OE | 15,000 | $44.53 | $667,884.00 | -96.2% |